MORC4

MORC4 is a nuclear, chromatin-associated ATPase that modulates nucleosome architecture and gene accessibility (PMID:33122719, PMID:17608765). Its ATPase activity depends on cooperative DNA binding by both its ATPase domain and its CW zinc-finger domain, which together engage the nucleosome core particle to enhance DNA wrapping around the histone core and impede access of DNA-binding proteins such as transcription factors (PMID:33122719). In cells, both the CW domain and catalytic ATPase activity are required for MORC4 to form nuclear bodies and to support S-phase progression (PMID:33122719). MORC4 also engages specific transcriptional partners to shape gene expression: it interacts with STAT3 to activate transcription of MID2 through STAT3 sites in the MID2 promoter (PMID:32764967), and it physically associates with the repressor PCGF1 to augment repression of the cell-cycle inhibitor CDKN1A, promoting proliferation (PMID:36932196). MORC4 protein abundance is controlled at multiple levels — by proteasomal degradation through the E3 ligase HECW2 (PMID:36932196) and by post-transcriptional repression via miR-193b-3p and miR-338-3p binding its 3' UTR (PMID:30320920, PMID:31908485). Beyond the nucleus, loss-of-function and gain-of-function studies in hepatocytes identify MORC4 as a regulator of hepatic lipid metabolism, controlling cholesterol and triglyceride homeostasis and the expression of lipid synthesis, uptake, and hydrolysis genes (PMID:40606021).

1. 2007 Low

   Established the domain architecture predicting MORC4 as a nuclear chromatin-associated protein, providing the structural rationale that later biochemical work would test.

   Evidence Protein domain annotation and antibody detection in DLBCL patient samples

   PMID:17608765

   Open questions at the time

   • Domain annotation without functional validation
   • No direct biochemical or cellular assay of any predicted activity
2. 2018 Medium

   Showed MORC4 abundance is post-transcriptionally controlled by a miRNA and that this loop is functionally consequential for cancer cell survival, answering how MORC4 levels are tuned.

   Evidence Dual-luciferase 3' UTR reporter, miRNA overexpression, and siRNA knockdown in breast cancer cells

   PMID:30320920

   Open questions at the time

   • Mechanism linking MORC4 level to apoptosis not defined
   • Single cancer context
3. 2019 Medium

   Confirmed a second miRNA (miR-338-3p) directly targets MORC4 and that MORC4 mediates its phenotypic effects, reinforcing miRNA-based control of MORC4.

   Evidence Luciferase reporter, RNA immunoprecipitation, and rescue experiments in breast cancer cells

   PMID:31908485

   Open questions at the time

   • Downstream molecular pathway from MORC4 to migration/invasion unresolved
4. 2020 High

   Defined the core biochemical mechanism: how MORC4 ATPase activity is activated and how the protein remodels nucleosome accessibility, the central molecular function question.

   Evidence Crystal structure of the ATPase-CW cassette plus ATPase assays, mutagenesis, and nucleosome core particle binding assays

   PMID:33122719

   Open questions at the time

   • Genomic targets of nucleosome engagement in vivo not mapped
   • Connection between in vitro NCP binding and specific gene programs not established
5. 2020 High

   Linked MORC4 catalytic and CW-domain functions to cellular outcomes (nuclear body formation, S-phase progression), connecting biochemistry to cell physiology.

   Evidence CW and catalytic mutant cell-based assays, nuclear body imaging, cell cycle analysis

   PMID:33122719

   Open questions at the time

   • Composition and function of MORC4 nuclear bodies undefined
   • Mechanism linking ATPase activity to S-phase progression unknown
6. 2020 Medium

   Identified a sequence-specific transcriptional output: MORC4 cooperates with STAT3 to activate MID2, showing MORC4 can promote gene expression in a partner-dependent manner.

   Evidence Reciprocal Co-IP, ChIP-qPCR, dual-luciferase reporter, knockdown/overexpression in breast cancer cells

   PMID:32764967

   Open questions at the time

   • Whether activation requires MORC4 ATPase/chromatin activity not tested
   • Single lab
7. 2023 Medium

   Revealed a repressive transcriptional role via PCGF1, showing MORC4 acts as a cofactor that augments repression of CDKN1A rather than repressing it alone.

   Evidence Co-IP, PCGF1 knockdown, overexpression, in vitro and in vivo tumor assays

   PMID:36932196

   Open questions at the time

   • Direct chromatin occupancy at CDKN1A not shown
   • Single Co-IP for interaction
8. 2023 Low

   Identified HECW2 as the E3 ligase targeting MORC4 for proteasomal degradation, defining a protein-stability control point.

   Evidence Co-IP and proteasome inhibitor experiments (inferred from abstract)

   PMID:36932196

   Open questions at the time

   • Limited mechanistic detail from abstract
   • Ubiquitination sites and conditions regulating degradation not defined
9. 2025 Medium

   Extended MORC4 function beyond cancer to hepatic lipid metabolism, showing it regulates cholesterol/triglyceride homeostasis and lipid gene expression.

   Evidence siRNA knockdown and overexpression in hepatocytes, TC/TG and lipid accumulation assays, gene expression analysis, IMPC knockout mouse data

   PMID:40606021

   Open questions at the time

   • Whether metabolic effects are direct chromatin-mediated transcriptional regulation not established
   • Single lab

• How MORC4's in vitro nucleosome-remodeling and ATPase activity connects to its specific transcriptional partnerships (STAT3, PCGF1) and metabolic functions remains unresolved.
• No genome-wide map of MORC4 chromatin occupancy
• Unknown whether catalytic activity is required for partner-specific transcriptional outputs
• Composition of MORC4 nuclear bodies undefined